The decision could reverse FDA approval of mifepristone, banning access to medication abortion for millions, even in states where it remains legal.
On this edition of Your Call, we discuss a court decision that could reverse FDA approval of mifepristone, one of two drugs used in over half of abortions. By 2021, over half of abortions in the US were medication abortions.
Matthew Kacsmaryk, a Trump appointed conservative judge with deep anti-abortion views, is hearing the case this morning in Amarillo, Texas.
A coalition led by the Alliance Defending Freedom, an anti-abortion group, filed the lawsuit challenging the FDA's two decades old approval of mifepristone, despite documented evidence that it is a safe and effective method of pregnancy termination.
Some legal scholars argue that Judge Kacsmaryk does not have the authority to force the FDA to withdraw approval of the drug.